Lithuanian University of Health Sciences
lsmuni.ltTotal trials
98
Active
20
Phase 3
3
Total enrollment
18,869
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Fluorouracil/folic acid | — | — | — | — | — | 1 | |
| Chemotherapy in regimen with Oxaliplatin, fluorouracil, folinic acid | — | — | — | — | — | 1 |
Next readouts
- 2025-06-01
Top conditions
- Allergic Asthma5
- Quality of Life4
- Sepsis4
- Airway Remodelling2
- Heart Failure2
- Obesity2
- Lung Cancer2
- Frailty Syndrome2
Frequently asked questions about Lithuanian University of Health Sciences
- How many clinical trials does Lithuanian University of Health Sciences have on ClinicalTrials.gov?
- Lithuanian University of Health Sciences is listed as the lead sponsor on 98 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Lithuanian University of Health Sciences's trials are in Phase 3?
- 3 of Lithuanian University of Health Sciences's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Lithuanian University of Health Sciences focus on?
- Lithuanian University of Health Sciences's most-studied conditions on ClinicalTrials.gov are Allergic Asthma, Quality of Life, Sepsis, Airway Remodelling, Heart Failure.
- When are Lithuanian University of Health Sciences's next clinical trial readouts?
- Lithuanian University of Health Sciences has 1 upcoming primary-completion readout tracked here; the soonest is “Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer”, expected around 2025-06-01.